Skip to content

Planning Your Everyday Life in Virtual Reality : a Study in Schizophrenia;

PLANning Your Every Day Life I Virtual REality : a Study Schizophrenia. Mathurin Serious Game

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04011774
Acronym
PlaniRev
Enrollment
144
Registered
2019-07-08
Start date
2018-10-09
Completion date
2024-08-09
Last updated
2022-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

Patients with schizophrenia , who visit frenquently day-care or day-care activities clinics, often experience difficulties of daily living and cognitive deficits. Living independently is a key for recovery. Cognitive remediation is a therapy which reduces deficit and improves daily living. Nowadays no program exists targeting neurocognitive functions in virtual reality which could mimic everyday life in a virtual town. Hypotheses : * Persons with schizophrenia experience difficulties in daily living and disabilities to plan in everyday life. PLANI-REV program, a serious game with a navigation in a virtual town, in a 15 weekly group sessions could reduce these difficulties compared to the initial assessment. This improvement could be maintained 6 months after the end of the program. * PLANI-REV could also improve prospective memory, attention, working memory, and visuospatial organization. * PLANI-REV could induce a clinical improvement, as well as better perception of self-efficiency, self esteem, quality of life, and conversation skills.

Interventions

OTHERPLANI-REV

Cognitive remediation program.

OTHERRELAXATION

Stimulation with no cognitive remediation.

Sponsors

Centre Hospitalier St Anne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 50 years old. * Diagnostic of schizophrenia or schizoaffective disorder (DSM V), attested by the MINI structured interview (Shehan et al. 1998) * Who visit for months or year, weekly or several times per week, a day care, or therapeutic activity units outpatients clinics and nursing homes * French Mother tongue * Consent of the legal representative caregiver for the patients under representative law (tutelle in French). * Clinical Stability - Therapeutic stability for at least one month. * National healthcare assurance

Exclusion criteria

* Central Neurological or non stabilized somatic diseases. * Treatments for somatic disease with putative psychotropic effect. * Electroconvulsive therapy in the last six months * Illetrism * IQ\< 70 established with the f-NART. * Substance misuse or dependence (except Nicotine) or toxic for more than 5 years.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of PLANI-REV : questionnaire scores10 monthsthe comparison pre/post PLANI-REV of the number of difficulties of daily life using the Profinteg questionnaire

Secondary

MeasureTime frameDescription
- Profinteg scores 6 months after PLANI-REV. Number of problematic activities; average score for difficulties of problematic activities.16 monthsTo improve pre/post PLANI-REV and 6 months after, neuropsychological performances in prospective memory, attention, working memory, executive functions, and visual and spatial organization

Countries

France

Contacts

Primary ContactIsabelle AMADO, MD
i.amado@ch-sainte-anne.fr+33 1 45 65 81 80
Backup ContactSylvie DOROCANT
s.dorocant@ch-sainte-anne.fr+33 1 45 65 77 28

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026